A look at the science that's been lost on long COVID
Since President Trump took office, hundreds of experts advising on science and research issues have been dismissed. One committee was on long COVID, an issue that doctors are desperate for help with.
Since President Trump took office, hundreds of experts advising on science and research issues have been dismissed. One committee was on long COVID, a
Read Full Story at NPR Health →Why This Matters
The dismissal of long COVID experts during President Trump’s tenure wasn’t just a bureaucratic reshuffle—it left a critical gap in the nation’s ability to confront a growing public health crisis. With millions still suffering from lingering symptoms and no clear federal strategy, the loss of institutional expertise has delayed research, fragmented care, and eroded trust in institutions at a time when coordinated science is most needed.
Background Context
Long COVID emerged as a defining health challenge of the pandemic’s later stages, yet federal response remained uneven. Early advisory committees were sidelined in favor of politically expedient decisions, leaving clinicians without federal guidance on everything from diagnostic criteria to treatment protocols. The result was a patchwork of care, with patients often dismissed or misdiagnosed by systems ill-equipped to handle their conditions.
What Happens Next
Without a dedicated federal framework, long COVID research will likely remain fragmented, dependent on underfunded academic institutions and advocacy-driven initiatives. The next administration will face pressure to either rebuild trust through new committees or risk ceding leadership in a field where global competitors are racing ahead. Meanwhile, patients will continue navigating a healthcare system that’s still catching up to the reality of long-term illness.
Bigger Picture
This episode reflects a broader erosion of scientific advisory capacity in federal agencies, particularly during political transitions. The pattern—experts dismissed, institutional knowledge lost, and crises managed in reactive mode—has become a recurring theme, raising questions about whether the U.S. can sustain the kind of long-term, evidence-based policymaking needed to tackle 21st-century health challenges.
